Related Experiment Video
Updated: Mar 24, 2026

13:28
Simple and Effective Administration and Visualization of Microparticles in the Circulatory System of Small Fishes Using Kidney Injection
Published on: June 17, 2018
9.0K
[THROMBOLYTIC THERAPY OF ACUTE VASCULAR DISEASES IN IRKUTSK REGION]
Klinicheskaia Meditsina
|March 19, 2016
Insights
Cardiovascular diseases are a leading cause of death. This study examines the development of thrombolytic therapy for heart attacks and strokes in the sparsely populated Irkutsk region.
Area of Science:
- Cardiology
- Neurology
- Public Health
Context:
- Cardiovascular diseases are the primary cause of mortality, morbidity, and disability globally.
- The Irkutsk region presents unique challenges due to its low population density.
- Effective treatment strategies for acute coronary syndrome and ischemic stroke are critical.
Purpose:
- To analyze the historical development and current state of thrombolytic therapy for acute coronary syndrome and ischemic stroke.
- To evaluate the accessibility and efficacy of these treatments in a low-density population area.
- To identify potential improvements in thrombolytic therapy delivery in remote regions.
Summary:
- The paper details the evolution of thrombolytic therapy for acute coronary syndrome and ischemic stroke within the Irkutsk region.
- It highlights the specific considerations and adaptations required for implementing such therapies in areas with low population density.
- The study provides insights into the challenges and successes of cardiovascular and cerebrovascular emergency care in this unique geographical setting.
Impact:
- Understanding the progression of thrombolytic therapy in diverse settings can inform treatment protocols.
- This research contributes to improving emergency care for cardiovascular and cerebrovascular events in low-density populations.
- Findings may guide public health initiatives and resource allocation for managing cardiovascular diseases in remote areas.
Abstract:
Cardiovascular diseases rank first as the cause of mortality, morbidity, and disability. This paper concerns evolution of thrombolytic therapy for acute coronary syndrome and ischemic stroke in the Irkutsk region characterized by low population density.